EX-23.01 3 w42839bex23-01.txt CONSENT OF KPMG LLP 1 EXHIBIT 23.01 Consent of Independent Auditors' The Board of Directors Guilford Pharmaceuticals, Inc.: We consent to the use of our report incorporated herein by reference and to the reference of our firm under the heading "experts" in the prospectus. Philadelphia, Pennsylvania November 16, 2000